Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moosa Mohammadi

Showing results (1-10 of 118) with videos related to

Pageof 12
Sort By:
F1000Research|July 10, 2018
A threshold model for receptor tyrosine kinase signaling specificity and cell fate determinationAllen Zinkle, Moosa Mohammadi
Nature Reviews. Drug Discovery|February 28, 2009
The FGF family: biology, pathophysiology and therapyAndrew Beenken, Moosa Mohammadi
Advances in Experimental Medicine and Biology|March 8, 2012
The structural biology of the FGF19 subfamilyAndrew Beenken, Moosa Mohammadi
Proceedings of the National Academy of Sciences of the United States of America|November 8, 2006
Hedgehogs like it sweet, tooAndrew Beenken, Moosa Mohammadi
Nature Reviews. Molecular Cell Biology|February 14, 2013
Exploring mechanisms of FGF signalling through the lens of structural biologyRegina Goetz, Moosa Mohammadi
Frontiers in Genetics|February 28, 2019
Structural Biology of the FGF7 SubfamilyAllen Zinkle, Moosa Mohammadi
Cold Spring Harbor Perspectives in Biology|June 5, 2013
Molecular mechanisms of fibroblast growth factor signaling in physiology and pathologyArtur A Belov, Moosa Mohammadi
Science Signaling|November 8, 2012
Grb2, a double-edged sword of receptor tyrosine kinase signalingArtur A Belov, Moosa Mohammadi
American Journal of Physiology. Cell Physiology|August 18, 2025
Asymmetric FGF receptor dimerization: implications for FGF23 biology and drug discoveryMohammed S Razzaque, Moosa Mohammadi
Expert Opinion on Therapeutic Targets|March 28, 2025
Can targeting the FGF23-αKlotho signaling system delay phosphate-driven organ damage?Mohammed S Razzaque, Moosa Mohammadi
Pageof 12

Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
F1000Research|July 10, 2018
A threshold model for receptor tyrosine kinase signaling specificity and cell fate determinationAllen Zinkle, Moosa Mohammadi
Nature Reviews. Drug Discovery|February 28, 2009
The FGF family: biology, pathophysiology and therapyAndrew Beenken, Moosa Mohammadi
Advances in Experimental Medicine and Biology|March 8, 2012
The structural biology of the FGF19 subfamilyAndrew Beenken, Moosa Mohammadi
Proceedings of the National Academy of Sciences of the United States of America|November 8, 2006
Hedgehogs like it sweet, tooAndrew Beenken, Moosa Mohammadi
Nature Reviews. Molecular Cell Biology|February 14, 2013
Exploring mechanisms of FGF signalling through the lens of structural biologyRegina Goetz, Moosa Mohammadi
Frontiers in Genetics|February 28, 2019
Structural Biology of the FGF7 SubfamilyAllen Zinkle, Moosa Mohammadi
Cold Spring Harbor Perspectives in Biology|June 5, 2013
Molecular mechanisms of fibroblast growth factor signaling in physiology and pathologyArtur A Belov, Moosa Mohammadi
Science Signaling|November 8, 2012
Grb2, a double-edged sword of receptor tyrosine kinase signalingArtur A Belov, Moosa Mohammadi
American Journal of Physiology. Cell Physiology|August 18, 2025
Asymmetric FGF receptor dimerization: implications for FGF23 biology and drug discoveryMohammed S Razzaque, Moosa Mohammadi
Expert Opinion on Therapeutic Targets|March 28, 2025
Can targeting the FGF23-αKlotho signaling system delay phosphate-driven organ damage?Mohammed S Razzaque, Moosa Mohammadi
Pageof 12